Management and mechanism of calciphylaxis in a patient treated with the FGFR inhibitor pemigatinib-a case report

CONCLUSIONS: Calciphylaxis is normally associated with advanced renal failure in the setting of high phosphate and calcium. However, the patient we present here did not have advanced renal failure or high calcium levels and calcium dysregulation. As FGFRi use becomes more widespread, the more important it becomes to identify and have a treatment strategy for this rare AE.PMID:38482230 | PMC:PMC10932651 | DOI:10.21037/jgo-23-139

Source: Ann Oncol - March 14, 2024 Category: Cancer & Oncology Authors: Sreenivasa R Chandana Austin Frisch Sergio Mendoza Ranu S Sinniah Oxana Crysler Ramandeep Banga Diane E Perkins Source Type: research